Estrace is a brand-name prescription medication containing estradiol, the most potent form of estrogen your body naturally produces. It is primarily used to treat menopause symptoms like hot flashes and vaginal dryness, but it also has approved uses for bone loss prevention, certain hormone deficiencies, and even some cancers. Estrace comes in two forms: oral tablets and a vaginal cream, each suited to different symptoms.
Menopause Symptom Relief
The most common reason people are prescribed Estrace is to manage moderate to severe menopause symptoms. As estrogen levels drop during menopause, many women experience hot flashes, night sweats, and vaginal changes like dryness, irritation, and painful intercourse. Estrace works by replacing some of the estrogen your body has stopped making.
For hot flashes and night sweats (called vasomotor symptoms), Estrace oral tablets are typically started at 1 to 2 mg daily. Clinical studies on estradiol show significant improvement after just two weeks of treatment, with hot flash frequency reduced by up to 84% at low doses. The goal is always to find the lowest dose that controls your symptoms, and treatment is often prescribed in cycles of three weeks on and one week off.
For vaginal symptoms specifically, the cream form of Estrace is applied directly to the vaginal tissue using a measured applicator. The cream delivers estrogen right where it’s needed, which can be preferable if vaginal dryness or discomfort is your main concern rather than hot flashes. To use it, you screw the applicator onto the tube, squeeze cream to the marked line, and insert it vaginally. Hands should be washed before and after.
Prevention of Osteoporosis
Estrogen plays a major role in maintaining bone density. When estrogen levels fall after menopause, bones lose minerals faster than they can rebuild, raising the risk of osteoporosis and fractures. Estrace is FDA-approved for preventing this postmenopausal bone loss. It’s generally considered for women who are under 60 or within 10 years of menopause onset, since the benefit-to-risk balance is most favorable during that window.
Low Estrogen From Other Causes
Menopause isn’t the only reason estrogen levels drop. Some women have low estrogen because their ovaries never fully developed (a condition called hypogonadism), because their ovaries were surgically removed, or because of primary ovarian insufficiency, where the ovaries stop functioning before age 40. In all of these situations, the body is missing estrogen it would normally have, and Estrace can fill that gap. The starting dose is the same 1 to 2 mg daily range used for menopause, adjusted based on how well symptoms respond.
Palliative Cancer Treatment
Estrace has two lesser-known but FDA-approved cancer-related uses, both for symptom relief rather than cure. In certain women and men with metastatic breast cancer, high-dose estradiol (30 mg daily) can help slow disease progression. It is also used in advanced prostate cancer that depends on male hormones to grow, at lower doses of 2 to 6 mg daily. These uses are far less common today than menopause treatment, and both require close medical supervision.
How It’s Typically Prescribed
Regardless of the reason for use, the guiding principle with Estrace is to use the lowest effective dose for the shortest time needed. Your prescriber will usually start on the low end and adjust upward only if symptoms aren’t adequately controlled. For menopause symptoms, this means beginning at 1 mg daily and increasing to 2 mg if necessary.
If you still have a uterus, estrogen taken alone can cause the uterine lining to thicken abnormally, raising the risk of endometrial cancer. For this reason, a progestogen is almost always prescribed alongside Estrace in women who haven’t had a hysterectomy. This combination keeps the uterine lining from building up unchecked. Women who have had a hysterectomy can typically take Estrace on its own.
Risks and Who Should Avoid It
Estrace carries a boxed warning for endometrial cancer risk when used without a progestogen. Until recently, its labeling also included boxed warnings for cardiovascular disease, breast cancer, and dementia. In early 2025, the FDA initiated removal of those additional warnings, though the endometrial cancer warning for estrogen-alone products remains.
Certain people should not take Estrace. This includes anyone with a current or past diagnosis of breast cancer, a history of blood clots or stroke, active heart disease, or liver disease. The medication is generally considered a safe option for healthy individuals experiencing bothersome menopause symptoms who are younger than 60 or within 10 years of menopause and don’t have those specific health conditions.
Common Side Effects
The most frequently reported side effects of Estrace include breast tenderness, headaches, nausea, bloating, and spotting or breakthrough bleeding. These tend to be most noticeable in the first few months and often ease as your body adjusts. With the vaginal cream, localized irritation or discharge can occur but is typically mild. Unusual leg swelling, chest pain, sudden severe headaches, or vision changes are rare but warrant immediate medical attention, as they can signal a blood clot.